BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10342734)

  • 1. EBV-B cells as antigen presenting cells in characterization of the self/donor context of allorecognition by T lymphocytes.
    Drouet C; Arvieux C; Devouassoux G; Csopaki F; Chavanon O; Brichon PY; Letoublon C; Zarski JP; Barnoud D; Pison C
    Transpl Immunol; 1998 Dec; 6(4):209-15. PubMed ID: 10342734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antigen presentation by heat-treated peripheral blood mononuclear cells and Epstein-Barr virus-transformed lymphoblastoid cell lines (EBV-LCL): heated EBV-LCL present alloantigen and soluble antigen but are deficient in the stimulation of autologous EBV-LCL primed T cells.
    Mandell RB; Hank JA; Chen BP; Robins HI; Sondel PM
    Hum Immunol; 1987 Jul; 19(3):163-77. PubMed ID: 3040644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
    Plotnicky H; Touraine JL
    Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct recognition of hepatocyte-expressed MHC class I alloantigens is required for tolerance induction.
    Paul-Heng M; Leong M; Cunningham E; Bunker DLJ; Bremner K; Wang Z; Wang C; Tay SS; McGuffog C; Logan GJ; Alexander IE; Hu M; Alexander SI; Sparwasser TD; Bertolino P; Bowen DG; Bishop GA; Sharland A
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL; Cunningham AC; Kirby JA
    Immunology; 1995 Nov; 86(3):325-30. PubMed ID: 8550066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV transformed B cell lines present to antigen specific T cell clones determinants different from those recognized by antibody in an HLA-DR linked restricted fashion.
    Chu E; Umetsu D; Yunis E; Geha RS
    Hum Immunol; 1983 Nov; 8(3):217-26. PubMed ID: 6196340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect T cell recognition in allograft rejection.
    Bradley JA
    Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR; Khanna R; Burrows JM; Moss DJ
    J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL; Volkman DJ; Buckley RH
    J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone.
    van Lochem EG; Bakker A; Snijder S; Aarts M; de Gast GC; Goulmy E
    Hum Immunol; 1995 Feb; 42(2):137-44. PubMed ID: 7744617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen recognition by MHC-incompatible cells of a human mismatched chimera.
    Roncarolo MG; Yssel H; Touraine JL; Bacchetta R; Gebuhrer L; De Vries JE; Spits H
    J Exp Med; 1988 Dec; 168(6):2139-52. PubMed ID: 2462006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
    J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.